PRM Pharma Launches First FDA-Approved 12.5 mg Chlorthalidone for Hypertension
WEST CONSHOHOCKEN, PA — PRM Pharma, LLC announced the nationwide launch of HemiClor® (chlorthalidone) 12.5 mg tablets, the first and only FDA-approved 12.5 mg formulation of chlorthalidone for adult hypertension. …
PRM Pharma Launches First FDA-Approved 12.5 mg Chlorthalidone for Hypertension Read More